The 3-deoxy-3,4-didehydro derivatives of 5-O-mycaminosyltylonolide, 5-O-(4-deoxymycaminosyl)tylonolide, and desmycosin have been prepared by treatment of the corresponding 3-O-sulfonyl derivatives with Nal in 2-butanone as the key step. The mechanistic difference in the formation of the 2,3-and 3,4-unsaturated derivatives from the same 3-0-sulfonyl derivative is discussed.
3-hydroxyl group in the macrolactone ring of mycaminosyltylonolides enhances the activity in comparison to the parent antibiotics.
In the course of the synthesis of the 3-deoxy derivatives we obtained the 2,3-unsaturated intermediates and these were selectively hydrogenated to give the desired products.
Deprotection of the above intermediates should give the corresponding 2,3-unsaturated analogs of the 3-deoxy compounds. Accordingly, 3-deoxy-5-O-(4-deoxymycaminosyl)-2,3-didehydro-23-O-(dimethylthexylsilyl)tylonolide 9,20-bis(ethylene acetal)2) was deprotected to give the 2,3-unsaturated analog (De-2,3-DT) of 3,4'-DT, and was found to be identical with that prepared by a different route by Tanaka3). This analog had less than one-half the activity of 3,4'-DT, suggesting that the 2,3-unsaturation does not enhance antibacterial activity as does 3-deoxygenation. In connection with this study we were interested to prepare the corresponding 3,4-unsaturated compounds. Such compounds are possible to give antibacterial spectra different from those for the 2,3-unsaturated compounds. This paper describes the synthesis of 3,4-unsaturated analogs of mycaminosyltylonolides and desmycosin. 5-O-Mycaminosyltylonolide dimethyl acetal4) (3) was treated with ter/-butyldimethylsilyl chloride in DMF to give the 23-0-silyl product (4) . Selective acetylation of 4 with acetic anhydride in toluene -acetonitrile gave the 2',4'-di-0-acetyl derivative (5). Sulfonylation of 5 with phenylmethanesulfonyl chloride gave the 3-O-sulfonyl derivative (6).
In a foregoing paper2) we reported that treatment of 5-O-(4-deoxy-4-iodomycaminosyl)-23-O-(dimethylthexylsilyl)-3-0-phenylmethanesulfonyltylonolide 9,20-bis(ethylene acetal), a structurally analogous compound to 6, with ammonia in aqueous methanol gave the corresponding 2,3-unsaturated compound, and the iodo precursor was prepared from the corresponding 3 ,4'-bis(0-phenylmethanesulfonyl) compoundby treatment with Nal in 2-butanone (30 minutes at 80°C). In the present study we utilized the same reaction conditions (Nal in 2-butanone), instead of ammonia in aqueous methanol, only extending the reaction period (8 hours at 80°C), whereupon the corresponding 3,4-unsaturated product (9) was produced in 84% yield, together with the C-20-deblocked 3-0-phenylmethanesulfonyl derivative (8). The 3-deoxy-3-iodo and 2,3-unsaturated products were not detected. This synthetic method effectively makes 3,4-unsaturated products. The 3,4-unsaturated structure 9 was confirmed by XHNMRspectrum, and also a Measured at 500MHzwith a JEOL Alpha 500. b In ppm down field from TMS. The shifts were confirmed by the 1H-1H correlated 2D spectra with aid of, in some cases, HOHAHA method.
by the AH and 13C NMRspectra of the final product (1) (see Tables 1 and 2) . To examine the effect of the 3-0-sulfonyl group the 3-0-mesyl (instead of 3-O-phenylmethanesulfonyl) derivative (7) was prepared, and this was treated with Nal. Again the same 3,4-unsaturated product 9 was obtained in 67%yield, although the reaction time required was longer, suggesting that any sulfonyl group will give the 3,4-unsaturation compoundunder similar conditions. Deacetylation of 9 gave 10, and desilylation of 10 gave the 3-deoxy-3,4-didehydro compound (1). 4'-Deoxy analog (2) of 1 was also prepared using a similar route. 5-O-(4-Deoxymycaminosyl)tylonolide dimethyl acetal5) (ll) was converted into the 23-O-silyl derivative (12), and after acetylation, the 2' -0-acetyl derivative (13) was converted to the 3-0-phenylmethanesulfonyl derivative (14) . Similar treatment of 14 with Nal, as described for 6 gave the 3,4-unsaturated product (15) in 73% yield. Deacetylation (to give 16) followed by acid-catalyzed desilylation and deacetalation gave 2. Preparation of 2 from 5-0-mycaminosyltylonolide6) was attempted by conducting simultaneous 3,4-unsaturation and 4'-iodination by treatment of a 3,4'-disulfonyl derivative with Nal. 5-0-Mycaminosyltylonolide 9,20-bis(ethylene acetal)2) (17) was treated with ter£-butyldimethylsilyl chloride to give the 23-O-silyl derivative (18), which was selectively sulfonylated with phenylmethanesulfonyl chloride to give the 3,4'-bis(O-phenylmethanesulfonyl) derivative (19). Iodination of 19 for a short period with Nal gave the 4'-deoxy-4'-iodo-3-O-phenylmethanesulfonyl derivative (20, 73%) . Longer reaction of 19 or 20 gave the 4'-deoxy-4'-iodo-3,4-unsaturation product (21) in 3 1 and 40% yields, respectively. The configuration at C-4' of 20 and 21 is assumed to be R (I down) on the basis of the discussion reported2) for the same iodination. The decreased yields of 21 compared with 9 and 15 are not clear, but possibly the unstable 4' -deoxy-4' -iodo intermediate(s) initially formed decomposes. Measured at 125MHz with a JEOL Alpha 500. In ppm down field from TMS. The shifts were confirmed by the 1H-13C correlated 2D spectra with aid of, in some cases, HMBC method.
To examine the difference in effectiveness of the halo anions (I , Br , and Cl ) in this reaction, 19 was treated with LiBr or Et4NCl in 2-butanone, whereupon similar 3,4-unsaturated 4'-bromo-4'-deoxy (22) and 4'-chloro-4'-deoxy derivatives (23) were prepared in 41 and 37% yields, respectively. The configurations at C-4' of 22 and 23 were determined to be R (halo atom down) on the basis of large coupling constants (10Hz) of JVA, (for 22) and JyA> and JA, 5, (for 23), which were confirmed by the 1H-1H 2D spectra. The above results indicate that all halo anions (excluding F~) catalyze the 3,4-unsaturation. Reaction mechanismof these reactions is not clear, but it is possible that a halo anion, which is a more neutral species than ammonia,attacks the 4-H to abstract it as a proton to form C-4 carbanion, which then induces elimination of the 3-sulfonyloxy group to give 3,4-unsaturation. As the 3-O-phenylmethanesulfonyl group and C(4)-# are expected to be (nearly) antiperiplanar relationship (a situation at which elimination readily occurs), formation of the 3,4-double bond will be facilitated by the catalysis of almost neutral halo anion. The spacial relationship between the groups concerned in 6 was ascertained by the HOHAHA measurement (see Fig. 1 ); lack of observation of a cross peak between 3-H and 4-H (this indicates no coupling) suggests that the projection angle between the two hydrogens should be~90°. As C-2 and 4-H is considered to be difficult to take antiperiplanar relationship by the nature of the macrolactone ring, the remaining 3-0-phenylmethanesulfonyl and 4-H should take antiperiplanar relationship. Onthe contrary, the more basic ammoniain aqueous methanol withdraws one of the protons at C-2, rather than the proton at C-4, to give 2,3-unsaturation1'2*, because 2-H hydrogens are activated by the neighboring, electron-withdrawing carboxyl group.
Reductive deiodination of 21 with Bu3SnH -azobis(isobutyronitrile) (AIBN) gave the 4'-deoxy derivative (24) in high yield. Acid-catalyzed deprotection of 24 as described for 16 gave 2.
3-Deoxy-3,4-didehydrodesmycosin (31) was also prepared by taking a similar route. Desmycosin In CDCI3 at 27°C measured at 500MHz with a JEOL Alpha 500; mixing time: 120msec. The shift values of3-H and 4-H were 6 4.92 and <5 1.61, respectively.
The crossing of the 3-H and 4-H is shown by x.
20-(ethylene acetal) (25), prepared from tylosin by acid-catalyzed hydrolysis in the presence of ethylene glycol, was acetylated to give the 2',4',4"-tri-O-acetyl derivative (26). After phenylmethanesulfonylation, the 3-sulfonate (27) was treated with Nal, and the 3,4-unsaturated derivative (28) was obtained in 67% yield. Successive deacetylation of 28 (to give 29), deacetalation (to give 30) and deacetylation gave 3-deoxy-3 ,4-didehydrodesmycosin (31) . Antibacterial spectra of 1, 2, and 31 are shown in Table 3 . Compounds1 and 2 showed similar antibacterial activity with that for the corresponding 3-deoxy-2,3-didehydro analogs (De-2,3-MT and De-2,3-DT), however, 2 showed activity against some resistant bacteria.
Experimental

General
Optical rotations were determined with a Perkin-Elmer 241 polarimeter. XHNMRspectra were recorded with Bruker WM250 (250 MHz) and JEOL Alpha 500 (500 MHz)spectrometers, and the chemical Table 3 . Antibacterial activity (MIC /xg/ml) of 1, 2 and 31 together with 5-0-(4-deoxymycaminosyl)tylonolide , and erythromycin (EM). shifts (<5) were measured down field from internal TMS. Mass spectra (MS) were determined using the fast atom bombardment method with a JMS-DX300(HF) mass spectrometer. Thin-layer chromatography (TLC) was performed on Kieselgel 60 F254 (Merck), and column chromatography on Kieselgel 60, 2304 00 mesh (Merck).
23-O-^rf-Butyldimethylsilyl-5-O-mycaminosyltylonolide
Dimethyl Acetal (4) A mixture of 3 (9.50g, 14.8mmol), imidazole (1.81 g), and ter/-butyldimethylsilyl chloride (2.67g, 17.7mmol) in dry DMF(95ml) was kept for 8 hours at room temperature. After addition of toluene (500 ml), the whole mixture was washed with aq NaHCO3and aq NaCl (both saturated) and the solution was dried (Na2SO4) and concentrated. 
5-O-(2,4-Di-O-acetylmycaminosyl)-23-O-^r/-butyldimethylsilyltylonolide
Dimethyl Acetal (5) A mixture of 4 (1.00g, 1.32mmol) and acetic anhydride (0.3ml, 3.2mmol) in toluene-acetonitrile (1 : 1, 40ml) was kept overnight at room temperature. After concentration of the solution, the residue dissolved in toluene was washed with aq NaHCO3(saturated), dried (MgSO4), and concentrated. The residue was purified by a short column with hexane-acetone (7 : 3) to give a solid of5, phenylmethanesulfonyl chloride (370 mg, 1.95 mmol) and the solution was kept at -20°C for 3 hours. Water (~0.4 ml) was added, and the solution was gradually warmed to room temperature. After concentration to a half of its volume, the mixture was extracted with toluene. The organic solution was washedwith aq NaHCO3(saturated), dried (MgSO4), and concentrated to give a solid of 6, 1.1 g (quant.), which was slightly unstable, and used for the next step without purification, TLC: Rf 0.3 (hexane -acetone, 7 : 3) (cf. 5: Rf 0.4); analytical sample was purified by column chromatography (hexane -acetone, 7 : 3), [ Acetal (7) To a solution of 5 (400mg, 0.48 mmol) in dry pyridine (8 ml) was added methanesulfonyl chloride (1 10 /A, 1.43 mmol) and the solution was kept at room temperature for 3 hours. Usual work-up as described for 6 gave, after chromatography (hexane-acetone, 7:3), a solid of 7, 402mg (92%), 5-O-(2,4-Di-O-acetylmycaminosyl)-23-O-^r/-butyldimethylsilyl-3-deoxy-3 ,4-didehydrotylonolide (9) From 6: To a solution of 6 (980mg, 0.84mmol) in dry 2-butanone (20ml) was added Nal (443mg, 2.95 mmol) and the mixture was stirred for 8 hours at 80°C under the atmosphere of nitrogen. After cooled to roomtemperature, the mixture was filtered, and the solution was concentrated. The residue was extracted with toluene, and the solution was washed with 10% aq Na2S2O3, dried (MgSO4), and concentrated. The residue gave two spots at Rf 0.33 (major, 9) and 0.25 (8); the products were separated by column chromatographywith hexane -acetone (7 : 3) to give solids of9, 641 mg (84% based on5) and 8, 87 mg (1 1 From 7: To a solution of 7 (170mg, 0.19mmol), in dry 2-butanone (3.4ml) was added Nal (83mg, 0.55 mmol) and the mixture was stirred for 18 hours at 80°C under the atmosphere of nitrogen. After usual post-treatment, the crude product was purified by column chromatography with hexane -acetone (14 : 5) to give a solid of 9, which was identical with the specimen prepared from 6, 96mg (67%), and another solid (possibly the 3-O-mesyl analog of8), 17mg (11%), MS m/z 874 (M+ 1)+, XH NMR (CDC13) 3 3.19 (3H, s, SO2CH3).
23-O-^r/-Butyldimethylsilyl-3-deoxy-3,4-didehydro-5-O-mycaminosyltylonolide
A solution of 9 (550mg) in methanol (ll ml) was heated at 60°C for 3 hours. Concentration gave a residue, which was washed with aq NaHCO3.The product was purified by chromatography with To anice-cold solution of 10 (230mg) in THF (4.6ml) was added 1 m aq HC1 (2.3 ml), and the solution was heated for 2hours at 40°C. TLC (CHCl3-MeOH-28% aq NH3, 10: 1 :0.1) of the solution gave a single spot at Rf 0.25 (cf. 10: Rf 0.35). Concentration to a small volume was followed by extraction of the residue with chloroform. The organic solution was washed with aq NaHCO3,dried (MgSO4), and concentrated.
The residue was chromatographed with CHCl3 -MeOH-28% aq NH3 (15 : Found: C 62.53, H 9.ll, N 1.77.
Compound 13 (884mg) was treated with phenylmethanesulfonyl chloride (390 mg) as described for 6 to give a solid of 14, 1.05g (quant.), which was used for the next step without purification, TLC: Rf 0.6 (CHCl3-MeOH, 10:1) (cf. ll: Rf0.5); MS m/z 938 (M+l)+, *H NMR (CDC13) 8 0.89 (9H, s, tert-butyl), 2.09 (3H, s, Ac), 3.27 and 3.33 (each 3H, s, OCH3 x2), 5.89 (1H, d, 13-H), 6.26 (1H, d, 10-H), -7.4 (5H, m, PhCH2SO2).
5-O-(2-O-Acetyl-4-deoxymycaminosyl)-23-
O-/er/-butyldimethylsilyl-3-deoxy-3,4-didehydrotylonolide Dimethyl Acetal (15) A mixture of 14 (950mg, 1.01mmol) and Nal (456mg, 3.04mmol) in dry 2-butanone (19ml) was stirred for 6.5 hours at 80°C. TLC(benzene-acetone, 2 : 1) of the solution showed a major spot at Rf0.55 with weak spots (Rf 0.5, 0.65, and 0.7; cf. 14: Rf 0.6). Similar treatment as described for 9 gave, after 
23-
Actal (16) Compound 15 (396mg) in methanol (8 ml) was treated as described for 10 to give a solid of 15, 324mg From 24: A solution of 24 (155mg) in acetonitrile (2.3ml)-0.5m aq HC1 (4.6ml) was heated for 2 hours at 40°C, and treated as described above to give a solid of 2, 86.6mg (76%), the product being identical with 2 obtained from 16. To a cold (-40°C) solution of 18 (1.00g, 1.25mmol) in dry pyridine (20ml) was added phenylmethanesulfonyl chloride (670mg, 3.51 mmol) and the solution was kept at -20°C for 1.5 hours. Water (0.7ml) was added and working-up as described for 6 gave a solid of 19, 1.38 g (quant.), which was unstable, and used for the next step without purification. A mixture of 19 (415mg, 0.38mmol) and Nal (141 mg, 0.94mmol) in dry 2-butanone (6.2ml) was stirred for 30 minutes at 80°C under the atmosphere of nitrogen. On TLC (cyclohexane -acetone, 3 : 1) , the solution showed a major spot at Rf 0.4 with a very weak spot at Rf 0.33 (cf. 19: Rf 0.28). Work-up as described for 9 (for chromatography, cyclohexane-acetone, 7 : 2 was used) gave a solid of 20, 290mg 1.32g, 1.19mmol) and Nal (940mg, 6.27mmol) in dry 2-butanone (25ml) was stirred for 6 hours at 80°C under the atmosphere of nitrogen. On TLC (benzene -ethyl acetate, 4 : 1), the solution showed several spots at Rf 0 (major), 0. 3 (major, 21), 0.43 (minor, 20), 0.47 (slight, 19) , and 0.6 (slight). Subsequent work-up as described for 9 followed by chromatography (benzene -ethyl acetate, 5.5: 1) gave a solid of21, 330mg (31% based on 18) and a solid of20, 130mg (10% based on 18 From 20: A mixture of 20 (120mg) and Nal (85mg) in dry 2-butanone-DMF (10: 1, 2.6ml) was stirred for 6 hours at 80°under the atmosphere of nitrogen. Work-upas described above gave a solid of 21, 40mg (40%).
5-O-(4-Bromo-4-deoxymycaminosyl)-23-
O-^r?-butyldimethylsilyl-3-deoxy-3 ,4-didehydrotylonolide 9,20-Bis(ethylene acetal) (22) A mixture of 19 (150mg, 0.14mmol) and LiBr (59mg, 0.68 mmol) in dry 2-butanone (3 ml) was stirred for 6 hours at 80°C. TLC (benzene-ethyl acetate, 4: 1) of the solution showed spots at Rf 0 (major), 0.23 (major, 22), 0.3 (slight), and 0.4 (slight). Subsequent work-up as described for 9 followed by chromatography (benzene-ethyl acetate, 4 : 1) gave a slightly unstable solid of 22, 47mg (41%), and a product mixture (41 mg) having Rf 0 (eluted with CHC13-MeOH, 10: 1 To a solution of 21 (230mg, 0.26mmol) in benzene (7.5 ml) were added Bu3SnH (0.22ml, 0.82mmol) and AIBN (10mg), and the solution was heated under the atmosphere ofAr for 2 hours at 80°C. On TLC with CHCl3-MeOH-28% aq NH3 (10: 1:0.1), the solution showed a single spot at Rf0.5 (cf 21: Rf 0.9). Concentration gave a residue, that was chromatographed by successive use of cyclohexane -acetone (3 : 1, 250ml)->CHCl3 (120ml)^CHCl3-MeOH-28% aq NH3 (10: 1 :0.1) to give a stannane-free solid of24, 185mg (94%), [ 2',4',4"-Tri-O-acetyldesmycosin 20-(Ethylene Acetal) (26) A solution of 25 (1.00g, 1.23mmol) and acetic anhydride (0.28ml, 2.94mmol) in acetonitrile (15ml) was kept overnight at room temperature. After concentration to a small volume, toluene (40 ml) was added, and the solution was washed vigorously with aq NaHCO3, dried (MgSO4), and concentrated to give the corresponding crude 2' ,4' -di-0-acetyl derivative, 1.1 g; Rf 0.7 (toluene -ethyl acetate, 1 : 2) (cf. 25: Rf 0.35). After dryness, the solid was dissolved in dry pyridine (16ml) containing acetic anhydride (0.116ml, 1.23mmol) and the solution was kept for 2 days at room temperature. On TLC (benzene-acetone, 2 : 1), the solution showed two spots at Rf 0.45 (minor, the 2',4'-di-0-acetyl derivative) and 0.7 (26). After work-up in a usual manner, the product was chromatographed with benzene-acetone (3 : 1) to give a solid of 26, 818mg (71%) along with the di-O-acetyl derivative, 187mg (17%).
